Lorena Blanco
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
-
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 15
- Peptidase Inhibition and Analysis 14
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Gorka Larrinaga (18 shared papers)José I. López (17 shared papers)Javier Gil (15 shared papers)Itxaro Pérez (15 shared papers)Jon Irazusta (7 shared papers)Begoña Sanz (11 shared papers)Francisco M. Pinto (6 shared papers)Maider Beitia (6 shared papers)
- Journals
- American Journal of Physiology-Renal Physiology (3 papers)Regulatory Peptides (3 papers)International Journal of Medical Sciences (2 papers)BMC Cancer (2 papers)PLoS ONE (2 papers)
- Partner nations
- SpainNetherlandsNorway
In The Last Decade
Lorena Blanco
22 papers receiving 448 citations
Peers
Comparison fields: 5 of 61
- Oncology 271
- Cancer Research 95
- Endocrinology, Diabetes and Metabolism 85
- Cellular and Molecular Neuroscience 83
- Pharmacology 54
Countries citing papers authored by Lorena Blanco
This map shows the geographic impact of Lorena Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Blanco more than expected).
Fields of papers citing papers by Lorena Blanco
This network shows the impact of papers produced by Lorena Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Blanco. The network helps show where Lorena Blanco may publish in the future.
Co-authors
The 25 scholars most cited alongside Lorena Blanco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 50 | |
| 2 | 2006 | 44 | |
| 3 | 2010 | 43 | |
| 4 | 2012 | 38 | |
| 5 | 2010 | 34 | |
| 6 | 2009 | 32 | |
| 7 | 2015 | 30 | |
| 8 | 2010 | 25 | |
| 9 | 2010 | 24 | |
| 10 | 2015 | 24 | |
| 11 | 2014 | 22 | |
| 12 | 2008 | 15 | |
| 13 | 2013 | 14 | |
| 14 | 2013 | 10 | |
| 15 | 2007 | 9 | |
| 16 | 2016 | 9 | |
| 17 | 2014 | 7 | |
| 18 | Changes in cell-surface peptidase activity in papillary renal cell carcinoma. | 2010 | 7 |
| 19 | 2016 | 6 | |
| 20 | 2015 | 5 |
About Lorena Blanco
Lorena Blanco is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 23 papers that have together received 450 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (14 papers), Renal cell carcinoma treatment (5 papers), Protease and Inhibitor Mechanisms (4 papers), Epigenetics and DNA Methylation (3 papers), Renin-Angiotensin System Studies (3 papers), Pancreatic function and diabetes (2 papers), Tuberculosis Research and Epidemiology (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Oncology (271 citations), Cancer Research (95 citations), Endocrinology, Diabetes and Metabolism (85 citations), Cellular and Molecular Neuroscience (83 citations) and Pharmacology (54 citations). Lorena Blanco has collaborated with scholars based in Spain, Netherlands and Norway. Frequent co-authors include Gorka Larrinaga, José I. López, Javier Gil, Itxaro Pérez, Jon Irazusta, Begoña Sanz, Francisco M. Pinto, Maider Beitia, Luz Candenas and Peio Errarte. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Regulatory Peptides, International Journal of Medical Sciences, BMC Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.